RECURRENT BILIARY TRACT CARCINOMA

Clinical trials for RECURRENT BILIARY TRACT CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT BILIARY TRACT CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat bile duct cancers

Disease control Ongoing

This study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…

Matched conditions: RECURRENT BILIARY TRACT CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

RECURRENT BILIARY TRACT CARCINOMA

Get alerted when new RECURRENT BILIARY TRACT CARCINOMA trials appear

New hope for Tough-to-Treat bile duct cancers